Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Healthcare Services Nano (38.1mn) 0 No activity — 15–50%
FI Optomed Oyj (OPTOMED)
Healthcare Services Nano (37.9mn) 0 No activity — 0–15%
Healthcare Services Nano (37.8mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (37.8mn) 0 No activity — 15–50%
Healthcare Services Nano (37.6mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (37.5mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (37.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (37.2mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (36.8mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (36.7mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (36.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (36.2mn) 1–5 $100K–$1M 0–15% 0–15%
SE Acarix AB (ACARIX)
Healthcare Services Nano (36.0mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (35.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (35.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (35.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (35.5mn) 0 No activity — 15–50%
Healthcare Services Nano (35.5mn) 0 No activity — —
Healthcare Services Nano (35.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (35.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (35.1mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (34.9mn) 0 No activity — 0–15%
Healthcare Services Nano (34.5mn) 0 No activity — —
Pharmaceuticals & Medical Research Nano (34.5mn) 0 No activity — 0–15%
Healthcare Services Nano (34.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (34.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (34.3mn) 0 No activity — 15–50%
Healthcare Services Nano (34.1mn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (33.9mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (33.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (33.1mn) 0 No activity — 15–50%
FR Genoway SA (ALGEN)
Pharmaceuticals & Medical Research Nano (33.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (32.9mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (32.9mn) 0 No activity — 0–15%
CA 1CM Inc (EPIC)
Pharmaceuticals & Medical Research Nano (32.8mn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Nano (32.5mn) 0 No activity — 0–15%
Healthcare Services Nano (32.4mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (32.3mn) 0 No activity — 0–15%
Healthcare Services Nano (32.3mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (31.7mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (31.6mn) 0 No activity — —
Healthcare Services Nano (31.5mn) 0 No activity — 15–50%
Healthcare Services Nano (31.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (30.8mn) 0 $1M–$10M 15–50% 0–15%
Pharmaceuticals & Medical Research Nano (30.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (30.6mn) 0 No activity — 0–15%
Healthcare Services Nano (30.4mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (30.4mn) 0 No activity — 0–15%
Healthcare Services Nano (30.4mn) 0 No activity — —
Healthcare Services Nano (30.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (30.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (30.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (30.2mn) 0 No activity — 0–15%
Healthcare Services Nano (30.2mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (30.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (29.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (29.7mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (29.4mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (29.3mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (29.2mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (29.1mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (28.9mn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Nano (28.8mn) 0 No activity — 0–15%
Healthcare Services Nano (28.8mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (28.4mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (28.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (28.3mn) 0 No activity — 15–50%
Healthcare Services Nano (28.3mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (28.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (28.1mn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Nano (28.0mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (27.8mn) 1–5 $100K–$1M 0–15% 0–15%
FR Poxel SA (POXEL)
Pharmaceuticals & Medical Research Nano (27.8mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (27.6mn) 0 No activity — 15–50%
Healthcare Services Nano (27.5mn) 0 No activity — 0–15%
Healthcare Services Nano (27.2mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (27.2mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (27.1mn) 0 No activity — 15–50%
IN Lyka Labs Ltd (LYKALABS)
Pharmaceuticals & Medical Research Nano (26.9mn) 0 No activity — 50%+
Healthcare Services Nano (26.8mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (26.7mn) 0 No activity — 0–15%
Healthcare Services Nano (26.6mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (26.6mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (26.6mn) 0 No activity — 0–15%
Healthcare Services Nano (26.5mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (26.5mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (26.4mn) 0 No activity — 0–15%
Healthcare Services Nano (26.3mn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Nano (26.3mn) 0 No activity — 15–50%
Healthcare Services Nano (26.0mn) 0 No activity — 15–50%
Healthcare Services Nano (25.8mn) 0 No activity — 15–50%
Healthcare Services Nano (25.8mn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Nano (25.7mn) 0 No activity — 15–50%
SE Integrum AB (INTEG-B)
Healthcare Services Nano (25.6mn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Nano (25.5mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (25.4mn) 0 No activity — 0–15%
Healthcare Services Nano (25.4mn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Nano (25.3mn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Nano (25.0mn) 0 No activity — 0–15%
Healthcare Services Nano (25.0mn) 0 No activity — 50%+